Chun-wa Chung

Title: Inventor Spotlight: Chun-wa Chung

Introduction

Chun-wa Chung, an accomplished inventor based in Stevenage, GB, has made significant contributions to the field of biomedical research, particularly in the development of innovative therapeutic solutions. With a portfolio of 5 patents, his work focuses on the mechanisms of protein interactions and the identification of new compounds for medical applications.

Latest Patents

Chung's latest innovations include groundbreaking patents that address important biological targets. One of his notable patents is on "Antigen binding proteins to oncostatin M (OSM)," which concerns proteins specifically designed to inhibit the interaction between OSM and its receptor, gp130. This invention not only outlines the binding properties but also introduces a process for humanizing antibodies and includes various pharmaceutical compositions and medical treatment methods.

Another significant patent by Chun-wa is the "Process for the identification of a compound which inhibits the binding of the first bromodomain of each of human BRD-2, BRD-3, and BRD-4." This patent describes methods for identifying compounds with molecular weights between 100 to 750 that can inhibit the binding of bromodomains to acetylated lysine residues, highlighting his focus on potential therapeutic applications.

Career Highlights

Throughout his career, Chun-wa Chung has worked with renowned organizations such as Glaxo Group Limited and GlaxoSmithKline LLC. His positions in these companies have allowed him to collaborate on various innovative projects and drive advancements in medical research.

Collaborations

Chun-wa has collaborated with esteemed colleagues in his field, including Gary Peter Bembridge and Susannah Karen Ford. Together, they have contributed to several projects aimed at enhancing the understanding and treatment of diseases through effective therapeutic strategies.

Conclusion

Chun-wa Chung is a notable figure in the realm of biomedical innovations, whose patents reflect a commitment to advancing healthcare through scientific research. His work continues to pave the way for new therapeutic options, showcasing the importance of innovation in medicine and the impact of dedicated inventors in the field.